金沙4399js网站

Vortioxetine Hydrobromide

Products > Others > Vortioxetine Hydrobromide

Vortioxetine Hydrobromide

Vortioxetine hydrobromide is indicated for the treatment of major depressive disorder. The product is in the α-crystalline form, which avoids patent protection of the original research drug. Once approved, it can be immediately launched for sale. Fokam Pharmaceutical's vortioxetine hydrobromide has a CDE registration status of "A".

【Category】API

【CAS】960203-27-4

【Specification】CHP/EP

【Certification】Manufacturing license



Next: Piracetam
XML 地图 | Sitemap 地图